MEDCHEM PARTNERS LLC
lexington, MA · Biotech · Private
Long-lasting inhaled nitric oxide (NO) donor molecules engineered for controlled pulmonary release
medchempartners.com →- Grants
- $1.9M
- 8 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Drug containing hydrogels which release nitric oxide for diabetic wound healing | $151,753 | |
| Federal grant | Department of Health and Human Services · Phase I · Dynasore Analogues for Ocular Surface Protection | $223,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Dynasore Analogues for Ocular Surface Protection | $556,030 | |
| Federal grant | Department of Health and Human Services · Phase I · Dynasore Analogues for Ocular Surface Protection | $223,295 | |
| Federal grant | Department of Health and Human Services · Phase I · Dynasore Analogues for Ocular Surface Protection | $108,736 | |
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Novel Inhaled Nitric Oxide Therapy For Pulmonary Treatments (COVID-19) | $256,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Combating Corneal HSV Infection with Novel Dynasore Analogues | $180,642 | |
| Federal grant | Department of Health and Human Services · Phase I · Combating Corneal HSV Infection with Novel Dynasore Analogues | $178,554 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2907 | Lyric Therapeutics | — | — |
| 2908 | Beacon Therapeutics | — | — |
| 2909 | ONCOARENDI THERAPEUTICS LLC | — | — |
| 2910 | MEDCHEM PARTNERS LLC | — | — |
| 2911 | Percev LLC | — | — |
| 2912 | Aiolos Bio | — | — |
| 2913 | GENSAIC, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Nitric Oxide Donorsapplication
- Nitric Oxide Donorsgranted
- Nitric Oxide Donorsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.